aap Implantate AG announces management board changes

aap Implantate AG has announced significant changes to its Management Board. CEO Rubino Di Girolamo will resign from his position and leave the board effective December 31, 2026, waiving the remainder of his contract term.

As part of a succession plan, the Supervisory Board has appointed Cornelius Fink to the Executive Board with immediate effect. Mr. Fink, who has held leadership roles within the company, will assume responsibility for the Trauma division and serve as Chief Operating Officer (COO).

Additionally, the Supervisory Board has appointed Nicole Kassel to the Management Board, where she will be responsible for Finance as Chief Financial Officer (CFO).